Edwards Lifesciences Corp EW

NYS: EW | ISIN: US28176E1082   30/04/2025
75,49 USD (-1,04%)
(-1,04%)   30/04/2025

3 juni 2024 · BD to Acquire Edwards Lifesciences' Critical Care Product Group for $4.2 Billion to Expand Smart Connected Care Solutions and Become an Advanced Monitoring Technology Leader · Persbericht

26 oktober 2023 · Clasp Iid One-Year Data Confirm Safety And Efficacy Of Edwards Pascal System For Degenerative Mitral Regurgitation · Persbericht

26 oktober 2023 · Triscend Ii Six-Month Data For First 150 Patients Successfully Demonstrate Safety And Efficacy Of Edwards Evoque System For Severe Tricuspid Regurgitation · Persbericht

25 oktober 2023 · Edwards Lifesciences Reports Third Quarter Results · Persbericht

24 oktober 2023 · Five-Year Data From Partner 3 Trial Demonstrate Excellent Survival For Patients Receiving Edwards Sapien 3 Valve · Persbericht

19 oktober 2023 · Edwards Evoque Transcatheter Tricuspid Valve Replacement System Receives Ce Mark · Persbericht

18 oktober 2023 · Edwards Lifesciences To Host Earnings Conference Call On October 25, 2023 · Persbericht

29 augustus 2023 · BetterInvesting™ Magazine Update on Edwards Lifesciences Corp. and 3M Company · Persbericht

28 augustus 2023 · Edwards Lifesciences To Present At The 2023 Wells Fargo Healthcare Conference · Persbericht

26 juli 2023 · Edwards Lifesciences Reports Second Quarter Results · Persbericht

19 juli 2023 · Edwards Lifesciences To Host Earnings Conference Call On July 26, 2023 · Persbericht

17 mei 2023 · Data From Benchmark Registry Demonstrate Improved Tavr Efficiency With Preserved Patient Safety · Persbericht

8 mei 2023 · Edwards' Aortic Valve With Resilia Tissue Shows Favorable Durability, Safety And Efficacy Outcomes In Seven Year Data · Persbericht

26 april 2023 · Edwards Lifesciences Reports First Quarter Results · Persbericht

19 april 2023 · Edwards Lifesciences To Host Earnings Conference Call On April 26, 2023 · Persbericht

6 maart 2023 · Edwards Highlights New Data At Acc Related To Lifetime Management Of Aortic Stenosis · Persbericht

31 januari 2023 · Edwards Lifesciences Reports Fourth Quarter Results · Persbericht

24 januari 2023 · Edwards Lifesciences To Host Earnings Conference Call On January 31, 2023 · Persbericht

5 januari 2023 · Edwards Lifesciences To Present At The 41St Annual J.p. Morgan Healthcare Conference · Persbericht

8 december 2022 · Edwards Lifesciences Outlines Growth Strategy At Annual Investor Conference · Persbericht

Mijn selecties